Pediatric Neurology News

A survey of community neurologists demonstrated four primary themes associated with the impact of the COVID-19 pandemic in this group, specifically highlighting “the unusual environment” in which these providers practice.

A session from SLEEP on pediatric sleep medicine that was intended for technologists focused on helping these professionals “deliver top quality care to even the youngest of patients,” according to the session’s chair.

Boston Children’s Hospital once again ranked as the No. 1 hospital in the country for pediatric neurology and neurosurgery in the U.S. News & World Report 2021-2022 Best Children’s Hospitals rankings, according to a press release.

Childhood-onset insomnia symptoms that continued into adulthood served as “strong determinants” of internalizing disorders in young adults, according to findings from a 15-year longitudinal study presented at the virtual SLEEP 2021 meeting.

Potential behavioral changes stemming from puberty were among the most common concerns of parents whose daughters presented for a premenarchal visit, researchers wrote in the Journal of Pediatric and Adolescent Gynecology.

Pediatric patients with headache experienced increased headache frequency, poorer anxiety and mood, less physical activity and more screen time during the COVID-19 pandemic, despite reported improvements in hydration, sleep and diet.

An international team of researchers at the NIH and other institutions have identified a novel form of ALS in a small set of children, starting at approximately 4 years of age, linked to the SPTLC1 gene, according to a press release.

Youth with psychogenic nonepileptic seizures experienced an increased risk for numerous psychiatric disorders compared with those with epilepsy and healthy controls, according to results of a nationwide matched cohort study.

Ongoing follow-up in the START phase 1 study supported “the long-term favorable safety profile” of Zolgensma in children aged up to 6 years with spinal muscular atrophy type 1, according to findings published in JAMA Neurology.

A 14-item self-reported scale improved the management of and provided guidance for narcolepsy type 1 among children and adolescents aged 10 to 18 years, according to study findings published in Neurology.